RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Molecular basis of thrombocytosis
2008-01-01 Cazzola, Mario
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation.
2010-01-01 Rumi, Elisa; Passamonti, Francesco; Arcaini, Luca; Bernasconi, Paolo; Elena, Chiara; Pietra, D; Brisci, A; Arbustini, Eloisa; Cazzola, Mario; Lazzarino, Mario
Monoclonal gammopathy of undetermined significance: a new proposal of workup
2013-01-01 Mangiacavalli, S; Cocito, F; Pochintesta, L; Pascutto, C; Ferretti, V; Varettoni, M; Zappasodi, P; Pompa, A; Landini, B; Cazzola, Mario; Corso, A.
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms.
2014-01-01 Rotunno, G; Guglielmelli, P; Biamonte, F; Rumi, Elisa; Cazzola, Mario; Vannucchi, A. M.
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms.
2019-01-01 Schischlik, F; Jäger, R; Rosebrock, F; Hug, E; Schuster, M; Holly, R; Fuchs, E; Milosevic Feenstra, Jd; Bogner, E; Gisslinger, B; Schalling, M; Rumi, E; Pietra, D; Fischer, G; Faé, I; Vulliard, L; Menche, J; Haferlach, T; Meggendorfer, M; Stengel, A; Bock, C; Cazzola, M; Gisslinger, H; Kralovics, R.
Mutations and prognosis in primary myelofibrosis
2013-01-01 Vannucchi, Am; Lasho, Tl; Guglielmelli, P; Biamonte, F; Pardanani, A; Pereira, A; Finke, C; Score, J; Gangat, N; Mannarelli, C; Ketterling, Rp; Rotunno, G; Knudson, Ra; Susini, Mc; Laborde, Rr; Spolverini, A; Pancrazzi, A; Pieri, L; Manfredini, R; Tagliafico, E; Zini, R; Jones, A; Zoi, K; Reiter, A; Duncombe, A; Pietra, D; Rumi, Elisa; Cervantes, F; Barosi, G; Cazzola, Mario; Cross, Nc; Tefferi, A.
MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance
2013-01-01 Varettoni, M; Zibellini, S; Arcaini, Luca; Boveri, E; Rattotti, S; Pascutto, C; Mangiacavalli, S; Gotti, M; Pochintesta, L; Paulli, Marco; Cazzola, Mario
MYD88 mutated and wild-type waldenström’s macroglobulinemia: Characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4
2018-01-01 Guerrera, M. L.; Tsakmaklis, N.; Xu, L.; Yang, G.; Demos, M.; Kofides, A.; Chan, G. G.; Manning, R. J.; Liu, X.; Chen, J. G.; Munshi, M.; Patterson, C. J.; Castillo, J. J.; Dubeau, T.; Gustine, J.; Carrasco, R. D.; Arcaini, L.; Varettoni, M.; Cazzola, M.; Treon, S. P.; Hunter, Z. R.
Myelodysplastic Syndrome (MDS)-Specific Comorbidity Index for Predicting the Impact of Extra-Hematological Comorbidities on Survival of Patients with MDS
2008-01-01 DELLA PORTA, MATTEO GIOVANNI; Kuendgen, A; Malcovati, Luca; Zipperer, E; Pascutto, C; Travaglino, E; Maffioli, M; Ambaglio, I; Invernizzi, Rosangela; Germing, U; Cazzola, Mario
Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.
2008-01-01 Cazzola, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Molecular basis of thrombocytosis | 1-gen-2008 | Cazzola, Mario | |
| Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation. | 1-gen-2010 | Rumi, Elisa; Passamonti, Francesco; Arcaini, Luca; Bernasconi, Paolo; Elena, Chiara; Pietra, D; Brisci, A; Arbustini, Eloisa; Cazzola, Mario; Lazzarino, Mario | |
| Monoclonal gammopathy of undetermined significance: a new proposal of workup | 1-gen-2013 | Mangiacavalli, S; Cocito, F; Pochintesta, L; Pascutto, C; Ferretti, V; Varettoni, M; Zappasodi, P; Pompa, A; Landini, B; Cazzola, Mario; Corso, A. | |
| Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms. | 1-gen-2014 | Rotunno, G; Guglielmelli, P; Biamonte, F; Rumi, Elisa; Cazzola, Mario; Vannucchi, A. M. | |
| Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms. | 1-gen-2019 | Schischlik, F; Jäger, R; Rosebrock, F; Hug, E; Schuster, M; Holly, R; Fuchs, E; Milosevic Feenstra, Jd; Bogner, E; Gisslinger, B; Schalling, M; Rumi, E; Pietra, D; Fischer, G; Faé, I; Vulliard, L; Menche, J; Haferlach, T; Meggendorfer, M; Stengel, A; Bock, C; Cazzola, M; Gisslinger, H; Kralovics, R. | |
| Mutations and prognosis in primary myelofibrosis | 1-gen-2013 | Vannucchi, Am; Lasho, Tl; Guglielmelli, P; Biamonte, F; Pardanani, A; Pereira, A; Finke, C; Score, J; Gangat, N; Mannarelli, C; Ketterling, Rp; Rotunno, G; Knudson, Ra; Susini, Mc; Laborde, Rr; Spolverini, A; Pancrazzi, A; Pieri, L; Manfredini, R; Tagliafico, E; Zini, R; Jones, A; Zoi, K; Reiter, A; Duncombe, A; Pietra, D; Rumi, Elisa; Cervantes, F; Barosi, G; Cazzola, Mario; Cross, Nc; Tefferi, A. | |
| MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance | 1-gen-2013 | Varettoni, M; Zibellini, S; Arcaini, Luca; Boveri, E; Rattotti, S; Pascutto, C; Mangiacavalli, S; Gotti, M; Pochintesta, L; Paulli, Marco; Cazzola, Mario | |
| MYD88 mutated and wild-type waldenström’s macroglobulinemia: Characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4 | 1-gen-2018 | Guerrera, M. L.; Tsakmaklis, N.; Xu, L.; Yang, G.; Demos, M.; Kofides, A.; Chan, G. G.; Manning, R. J.; Liu, X.; Chen, J. G.; Munshi, M.; Patterson, C. J.; Castillo, J. J.; Dubeau, T.; Gustine, J.; Carrasco, R. D.; Arcaini, L.; Varettoni, M.; Cazzola, M.; Treon, S. P.; Hunter, Z. R. | |
| Myelodysplastic Syndrome (MDS)-Specific Comorbidity Index for Predicting the Impact of Extra-Hematological Comorbidities on Survival of Patients with MDS | 1-gen-2008 | DELLA PORTA, MATTEO GIOVANNI; Kuendgen, A; Malcovati, Luca; Zipperer, E; Pascutto, C; Travaglino, E; Maffioli, M; Ambaglio, I; Invernizzi, Rosangela; Germing, U; Cazzola, Mario | |
| Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis. | 1-gen-2008 | Cazzola, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 483
- 1 Contributo su Rivista::1.1 Arti... 469
- 1 Contributo su Rivista::1.5 Abst... 14
Data di pubblicazione
- 2020 - 2024 26
- 2010 - 2019 170
- 2000 - 2009 127
- 1990 - 1999 77
- 1980 - 1989 73
- 1974 - 1979 10
Editore
- Macmillan Magazines Limited:Porte... 4
- Blackwell Science Limited:PO Box ... 3
- American Society of Hematology:19... 2
- American Society for Biochemistry... 1
- Elsevier Science Incorporated / N... 1
- John Wiley & Sons Incorporated:Cu... 1
- Marcel Dekker Incorporated:270 Ma... 1
Rivista
- HAEMATOLOGICA 103
- BLOOD 96
- BRITISH JOURNAL OF HAEMATOLOGY 54
- LEUKEMIA 35
- AMERICAN JOURNAL OF HEMATOLOGY 17
- AMERICAN JOURNAL OF HEMATOLOGY 11
- JOURNAL OF CLINICAL ONCOLOGY 10
- SCANDINAVIAN JOURNAL OF HAEMATOLOGY 9
- THE NEW ENGLAND JOURNAL OF MEDICINE 9
- BLOOD 6
Keyword
- Myelodysplastic syndrome 60
- Anemia 45
- Iron 31
- Myeloproliferative neoplasm 28
- JAK2 22
- prognosis 19
- Erythropoietin 18
- Erythropoiesis 17
- mutation 17
- MYELODYSPLASTIC SYNDROME 17
Lingua
- eng 477
- ita 2
- spa 1
Accesso al fulltext
- no fulltext 483